Pangaea

📍 South San Francisco, United States🗓 Founded 2017👥 19 employees💰 Last funded Feb 2021
Biotechnology Research🌐 pangaeadata.ai
Website LinkedIn
Pangaea Data is headquartered in London with offices in San Francisco and Hong Kong. Pangaea’s AI-driven software product, PIES, has proven to find 6x more suitable patients including those who are undiagnosed and miscoded, improve screening success rates by 400%, and save 90% in time by automatically generating clinical narratives for regulatory reports, from tables, figures, and listings. This is achieved through Pangaeas novel unsupervised Natural Language Processing (NLP) and first-of-its-kind Natural Language Generation (NLG) methods which respectively extract and summarize intelligence from textual and multi-modal health data at scale and in a federated privacy preserving manner. Through high impact peer reviewed publications, Pangaeas product has demonstrated 85 - 90% accuracy, which is transformatively higher than generic language models like GPT-3, supervised NLP, and relational extraction approaches. The founders at Pangaea have secured more than $200 million in research funding through their work. All customer success stories and peer-reviewed publications are available through Pangaeas website.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2017
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
1
Hong Kong
1
Frequently asked questions
Who invested in Pangaea?
Pangaea has 2 investors on record on gritt.io, 2 mid-stage.
When did Pangaea last raise funding?
The most recent investment in Pangaea recorded on gritt.io was in February 2021.
When was Pangaea founded?
Pangaea was founded in 2017.
What industry is Pangaea in?
Pangaea operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Pangaea based?
Pangaea is headquartered in South San Francisco, United States.